Loading...

ENTX ENTERA BIO LTD Expansion Plans 8-K Filing

NTR

NTX

ENTERA BIO LTD

(ENTX)

2025 8-K

Show Summary

Summary

New Drug Application Agreement

Financial Statements

Financial Results

Collaboration Agreement

Advisory Vote Update

Financial Results

Financial Results Announcement

Annual Meeting Voting Results

Financial Results Announcement

Financial Results Announcement

Compliance Regained

Registration Statement Filed

Extension for Compliance wi...

Private Placement

Earnings Report

Annual Meeting Voting Results

Financial Results Announcement

Appointment of Director

Earnings Report

Earnings Report

External Links:

On March 16, 2025, Entera Bio Ltd entered a collaboration agreement with OPKO Health to develop an oral treatment for obesity and related disorders, sharing 40% of costs and proceeds, and issued 3,685,226 shares for $8 million at $2.17 each.

AI Assistant

ENTERA BIO LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.